Efficient site-directed mutagenesis (SDM) is a powerful tool for the analysis of the function of DNA sequences. The polymerase chain reaction (PCR) (4, 9) and commercially available methods for in vitro selection of mutated unmethylated DNA (Stratagene, La Jolla, CA, USA) have been used increasingly as rapid alternatives to classical methods of site-specific mutation (11) . Generating mutations at the termini of PCR-amplified fragments by incorporating mismatches at the 5 ′ ends of priming oligonucleotides is usually an uncomplicated procedure. However, mutation of specific sites that are internal to the flanking primers is more difficult. The most widely applied PCR procedure for SDM has been the megaprimer method (2) . The approach involves two sequential PCR amplifications. Double-stranded (ds)DNA produced from a flanking and mutagenic primer during the initial reaction is used as a megaprimer for the second amplification step with the opposite flanking primer. A number of modifications of this method have been described (5, 6, 8, 10) to overcome poor yields of the final PCR product resulting from variable megaprimer efficiency. The double-stranded nature of the megaprimer diminishes its effectiveness as a primer for the second PCR. Also, the addition of residues to the 3 ′ ends of PCR fragments that are not template dependent (1) might result in mismatches and inhibition of DNA polymerase extension during the second amplification reaction.
An uncomplicated method for SDM that is based on standard methods of PCR, restriction digestion, ligation and plasmid cloning is described here. Two contiguous DNA fragments are amplified with two pairs of primers. The internal primers introduce the intended mutation(s) at the sequence where the amplified DNA fragments adjoin each other (Figure 1 ). Hexanucleotide recognition sequences of blunt-cutting restriction endonucleases are incorporated to permit ligation of the fragments at the exact point of their contiguity. Restriction digestion also enables removal of extra 3 ′ residues that might have been added during PCR. After fusion, the six nucleotides at the point of ligation in the mutated sequence comprise two trinucleotides derived from each of the two blunt-cutting restriction sites. Thus, the sequence requirement to carry out the procedure is the presence of two adjoining trinucleotides in the mutated DNA, each of which includes the 5 ′ half and the 3 ′ half of the recognition sites of two different blunt-cutting restriction enzymes. There are presently 20 restriction enzymes available commercially (New England Biolabs, Beverly, MA, USA) that digest symmetrically at individual palindromic hexanucleotide sequences to produce blunt ends. The probability of a random trinucleotide comprising the appropriate half of a blunt-cutting recognition sequence is thus approximately 0.3 (20 restriction sites out of 64 possible trinucleotide sequences). The probability of two adjoining trinucleotides constituting a point of fusion is approximately 0.1 (0.3 × 0.3). On average, in a randomly chosen sequence, such a hexanucleotide should be found every 15 bp (15 bp comprise 10 overlapping hexanucleotides). Moreover, the site of a single mutagenic primer mismatch is on average a maximum of 7 bp from the closest possible ligation point. This is sufficiently close to the 5 ′ end of a standard length primer (for example, a 30-mer) to allow incorporation of a noncomplementary 5 ′ end to generate a restriction site, while at the same time permitting matched hybridization at the 3 ′ end to allow DNA polymerase extension. Statistically therefore, it is unlikely that the number of nucleotides between the site of the intended mutation and the point of fusion is too great for a PCR primer to incorporate a restriction site at the 5 ′ end and matched hybridization at the priming 3 ′ end.
We applied the approach to mutate three specific bases in a template sequence encoding the RNA encapsidation signal ( ε ) of the hepatitis B virus (HBV) AYW subtype. The mutated HBV DNA generates pre-genomic HBV RNA of the ADW subtype and with a mutation commonly found in ε , which is associated with a HBV e antigen-negative phenotype among chronic HBV carriers in sub-Saharan Africa (8) . In our hands, attempts to generate the mutations using the megaprimer method were unsuccessful. DNA encoding the wild-type (WT) AYW ε was excised with Hin dIII and Xba I from the plasmid pCH3068-sCX (7) and cloned into the corresponding restriction sites of pBluescript ® II Phagemid Vector (Stratagene) to produce ε -WT-AYW. This recombinant plasmid included HBV sequences extending from coordinates 1786-2152 of the HBV genome (3) and was used as a PCR template DNA to generate the mutant ADW εsequence. The primer combination to amplify the 5 ′ end of the region encoding ε (5 ′ ε fragment) was:
The forward primer comprised sequence complementary to the pBluescript multiple cloning site (MCS) (in -
5 ′ -ACGTGAATTCC AGT ACT t TTC-AAGCCTCCAAGCTG-3 ′ (forward) and 5 ′ -GGTCTCTAGAAGCAGGATCC-TC-3 ′ (reverse) The forward primer corresponded to HBV plus strand DNA of coordinates from 1859-1879 (italics) and included a 5 ′ noncomplementary sequence to incorporate Sca I (underlined) and Eco RI restriction sites. The mutagenic base in the forward primer is indicated in bold lowercase. The point of contiguity of the two amplified fragments is at the sites of digestion by the blunt-cutting restriction enzymes Sca I and Sma I. The 3 ′ reverse primer is complementary to plus strand HBV sequences from 2152-2131. This primer also includes a naturally occurring Xba I site at the 5 ′ end. DNA was amplified with 2.5 U of Taq DNA Polymerase (Promega, Madison, WI, USA) using standard PCR components. There were two stages to the thermal cycling. The reaction was initiated with 5 cycles of 95°C for 1 min, 50°C for 1 min, then 72°C for 1 min, followed by 25 cycles of 95°C for 1 min, 58°C for 1 min, then 72°C for 1 min and concluded with an extension at 72°C for 10 min. After amplification, the 5 ′ εfragment was digested with Hin dIII and Eco RI, and the 3 ′ ε fragment was digested with Eco RI and Xba I. These two fragments were ligated at their Eco RI sites and inserted into the Hin dIII and Xba I restriction sites of pBluescript to produce the plasmid ε -Intermediate. The intervening adapter sequence containing the Eco RI site was removed from ε -Intermediate by digestion with Sca I (partial) and Sma I. The blunt ends were ligated to abolish the restriction sites and to reconstitute the mutant εsequence in the resulting ε -Mutant-ADW plasmid. Restriction mapping eliminated most of the unwanted clones. ε -WT-AYW, ε -Intermediate and ε -Mutant-ADW plasmids were used as templates for dideoxy sequencing with Sequenase ® (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The HBV sense-strand sequences in the regions manipulated to generate the three site-specific mutations are:
c GGGGAATTCC AGTACTt TTCAAGCC-3 ′ and ε -Mutant-ADW 5 ′ -TGT a CATGT CC cACTt TTCAAGCC-3 ′ . The bases targeted for mutagenesis and the resulting mutants are indicated in bold lowercase. The Sca I and Sma I restriction sites in ε -Intermediate and the sequences derived from these sites at the fusion point of ε -Mutant-ADW are underlined.
The procedure outlined here focuses on using blunt-cutting restriction endonucleases that have hexanucleotide recognition sites. Restriction enzymes that recognize tetranucleotide sequences are more frequent cutters and can be of limited use, as they are likely to digest elsewhere within the amplified DNA. Similarly, the procedure would be complicated if a blunt-cutting hexanucleotide recognition site required for the fusion occurred within the amplified sequence. With the available panel of restriction enzymes that produce sticky ends, the statistical probability of adjoining tetra-or pentanucleotide sequences with complementary sequences derived from sticky-ended restriction sites is very low and unlikely to occur at the site of an intended mutation. The method described here might apply type IIS restriction enzymes to generate mutated DNA sequences. Incorporation of nonpalindromic recognition sites at the 5 ′ termini of the mutagenic primers would allow digestion and ligation at a fixed distance from the type IIS recognition site to reconstitute a mutated sequence. In our experiments, we performed a modification of the basic procedure outlined in Figure 1 , by including an intermediate plasmid with an additional Eco RI restriction site. This improves the efficiency of the cloning of the PCR products by generating sticky ends for ligation. This step is not essential and should be omitted when using a bluntcutting restriction endonuclease that is inhibited by methylation.
The results from applying our approach demonstrate the mutation of three bases of a HBV sequence using an alternative PCR-based, SDM method. The technique obviates the variable efficiency of using doublestranded megaprimers and direct ligation of unmodified PCR products. Based on the commercially available panel of blunt-cutting restriction enzymes that recognize hexanucleotide palindromic sequences, this method might be conveniently applied to generating mutations in target sequences. The use of polymerase chain reaction (PCR)-based methods for screening recombinant libraries has proven to be convenient, rapid and cost-effective in comparison with the commonly used hybridization procedures. PCR-based screening methods can be broadly classified as being of two types: (i)the cDNA sequences are directly derived from the PCR products themselves, and (ii) the PCR products are utilized solely to isolate the desired clone in a cDNA library, and the final cDNAs are sequenced from this clone (1,2,5,7). The sequence determined from an isolated clone is more reliable than that from subcloned PCR products, because the subcloned fragments might contain mutations relative to the original cDNA. Here, we report a simple and reliable method of the latter type. This method is effective because the frequency of the desired clone in the library steadily increases with each selection round. In addition, this method simplifies the culturing of recombinant cells and requires minimal DNA purification for the PCR amplification, resulting in an economical and laborsaving cDNA cloning. Figure 1 shows a flow chart of the procedure. To apply this method to cDNA cloning, it is necessary to first determine a partial cDNA sequence of sufficient length to establish a primer pair for PCR amplification of the desired cDNA. A cDNA library, constructed by transforming Escherichia coli cells with cDNAs in plasmid vectors, is used as a template. The library is amplified by culturing in Terrific Broth (8) containing the appropriate antibiotics and shaking at 30°C overnight. It is then separated into aliquots and stored in medium containing 20% (vol/vol) glycerol at -80°C. Take care not to incubate the cells at >30°C, because clones are prone to deletions at >30°C (4,6). To confirm the presence of the desired clones in the library and
Sergio

